2018
DOI: 10.1007/s10517-018-4256-x
|View full text |Cite
|
Sign up to set email alerts
|

Oxidative Status in Different Areas of the Cerebral Cortex of Wistar Rats during Focal Ischemia and Its Modulation with Carnosine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 9 publications
0
5
0
Order By: Relevance
“…In fact, our previous study demonstrated that the overexpression of carnosine synthase increased 2-oxo-carnosine production in H 2 O 2 - or rotenone-treated SH-SY5Y cells, resulting in the cytoprotection from the oxidative stress-induced cell death [ 4 ]. Taken together, the conversion of IDPs to 2-oxo-IDPs may be critical for the protective effects of IDPs against the various oxidative stress-related diseases previously reported [ 39 , 40 , 41 , 42 , 43 , 44 , 45 ].…”
Section: Discussionmentioning
confidence: 81%
See 2 more Smart Citations
“…In fact, our previous study demonstrated that the overexpression of carnosine synthase increased 2-oxo-carnosine production in H 2 O 2 - or rotenone-treated SH-SY5Y cells, resulting in the cytoprotection from the oxidative stress-induced cell death [ 4 ]. Taken together, the conversion of IDPs to 2-oxo-IDPs may be critical for the protective effects of IDPs against the various oxidative stress-related diseases previously reported [ 39 , 40 , 41 , 42 , 43 , 44 , 45 ].…”
Section: Discussionmentioning
confidence: 81%
“…A previous study demonstrated that small amounts of hydrazine (0.01-0.20%), a strong reductant, were present in various sources of commercial carnosine, thereby interfering with lipid oxidation [38]. These results suggest that impurities in the standards could affect the antioxidant capacity of IDPs and the protective effects of IDPs against various oxidative stress-related diseases previously reported [39][40][41][42][43][44][45].…”
Section: Discussionmentioning
confidence: 86%
See 1 more Smart Citation
“…These effects include decreased plasma glucose and amelioration of diabetic complications (e.g., nephropathy, ocular damage, and retinopathy) in diabetic mice (Lee et al 2005;Pfister et al 2011); reduced lipid oxidation and augmented anti-oxidative capacities [e.g., restoring of blood glutathione and basal activities of antioxidant enzymes in aging rats (Aydin et al 2010a,b;Hipkiss and Brownson 2000)] and in pigs (Ma et al 2010); amelioration of acetaminophen-induced liver injury (Yan et al 2009), thioacetamide-or hyperammonemia-induced liver cirrhosis (Aydin et al 2010a,b;Jamshidzadeh et al 2017b), and ethanol-induced chronic liver injury in rats (Liu et al 2008). Dietary supplementation with carnosine also results in decreases in malondialdehyde, oxidative stress (including ischemic oxidative stress and cerebral ischemia), and ethanol-induced protein carbonyls in brains (Berezhnoy et al 2019;Fedorova et al 2018); amelioration of neurological disorders, including autism spectrum disorder in children (Chez et al 2002;Kawahara et al 2018); protection against cardiovascular injury (Abplanalp et al 2019;Artioli et al 2019) and bleomycin-induced lung fibrosis in rats (Cuzzocrea et al 2007); cardiomyopathy in rats induced by chemotherapeutic agents that cause hydroxyl radical formation and lipid peroxidation (Dursun et al 2011); ROS-induced renal damage in mice (Fouad et al 2008); and promotion of wound healing in rodents (Ansurudeen et al 2012). Through augmenting respiratory burst in neutrophils and their production of ROS, as well as modulating the release of the virulent influenza virus from activated neutrophils, oral administration of carnosine and anserine reduces virus dissemination in humans (Babizhayev and Deyev 2012;Babizhayev et al 2014).…”
Section: Health Benefits Of Carnosine Supplementationmentioning
confidence: 99%
“…L-carnosine has clinical evidence for its action against chemotherapy-induced toxicities [69,70], but no research has been conducted on its anticancer activity. Pre-clinical evidence from cardiovascular research suggests that L-carnosine improves functional capability in ischemia circumstances [71][72][73][74][75][76][77][78]. Similarly, pre-clinical evidence from diabetes studies showed that L-carnosine had an effect on diabetes [79,80] and its complications [81][82][83].…”
Section: Discussionmentioning
confidence: 99%